CompletedPhase 1

The Capillary Index Score Trial

United States57 participantsStarted 2016-03-01

Plain-language summary

This study seeks to investigate the capillary index score (CIS) to further improve patient selection of endovascular treatment (EVT) in acute ischemic stroke (AIS). The hypothesis or idea being tested: Patients with favorable CIS who are successfully revascularized with EVT can have successful outcomes with an extended time window for treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Anterior circulation acute ischemic stroke due to blockage of the intracranial internal carotid artery or middle cerebral artery (M1)
✓. Within 24 hours of onset of symptoms
✓. NIHSS Score is 8 or greater

Exclusion criteria

✕. Contra-indication for IAT found on initial CT
✕. Intracranial hemorrhage
✕. Stroke mimics (tumor, herpetic encephalitis, etc.)
✕. More than 1/3 hypodensity on non-enhanced head CT prior to intervention
✕. ASPECT Score less than 6
✕. Pre-existing disability defined as modified Rankin Scale (mRS) score more than 2
✕. Pregnant women

What they're measuring

Modified Rankin Score (mRS) Between Favorable CIS Group Versus Poor CIS Group.

Timeframe: 90 days

Trial details

NCT IDNCT02618031

SponsorFiras Al-Ali

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-08-31

Results submitted2019-07-02

View on ClinicalTrials.gov More Acute Stroke trials